Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE trial.
TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for electrophysiology (EP) mapping and ablation ...
The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...
Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial ...
In this case, we describe a case of atypical slow-slow AVNRT in a patient with dextrocardia and an unusual His bundle position in the low posterior septum of the morphologic right atrium. The His ...
Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire catheters." ...
Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback